Literature DB >> 1362753

The management of acute, serous and chronic otitis media: the role of anaerobic bacteria.

I Brook1, P Burke.   

Abstract

Otitis media (OM) is a common childhood disease and one which can cause significant morbidity. A knowledge of the pathogens responsible for OM enables the most appropriate treatment regimen to be selected and thus minimizes further complications which may require hospital admission and surgery. The microbiology of acute, serous and chronic OM is reviewed, with particular regard to the role of anaerobic bacteria. Anaerobes, mainly Gram-positive cocci, have been recovered from 25% of the ear aspirates of patients with acute otitis media. In a study of serous OM, anaerobic bacteria were recovered in 12% of the culture-positive aspirates. The predominant anaerobes were Gram-positive cocci and pigmented Prevotella. Several studies have reported the recovery of anaerobes from about 50% of patients with chronic OM and those with cholesteatoma. The predominant anaerobes were Gram-positive cocci, pigmented Prevotella, Porphyromonas sp., Bacteroides spp. and Fusobacterium spp. Many of these organisms produce beta-lactamase which might have contributed to the failure of the patients to respond to penicillins. The appropriate antimicrobial therapy for acute, serous and chronic otitis media is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362753     DOI: 10.1016/s0195-6701(05)80010-6

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Topical treatment of chronic suppurative otitis media.

Authors:  Sam J Daniel
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 2.  Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.

Authors:  Jane Easton; Stuart Noble; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Microbiology of chronic suppurative otitis media at Queen Elizabeth Central Hospital, Blantyre, Malawi: A cross-sectional descriptive study.

Authors:  M Chirwa; W Mulwafu; J M Aswani; P W Masinde; R Mkakosya; D Soko
Journal:  Malawi Med J       Date:  2015-12       Impact factor: 0.875

4.  Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-14       Impact factor: 3.267

Review 5.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

6.  Long noncoding RNAs show differential expression profiles and display ceRNA potential in cholesteatoma pathogenesis.

Authors:  Juanjuan Gao; Qi Tang; Xiaohui Zhu; Shihua Wang; Yongli Zhang; Wenbin Liu; Zhiqiang Gao; Hua Yang
Journal:  Oncol Rep       Date:  2018-03-16       Impact factor: 3.906

7.  TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.

Authors:  Yu Si; Yu Bin Chen; Sui Jun Chen; Yi Qing Zheng; Xiang Liu; Yi Liu; Huai Li Jiang; Guo Xu; Zhuo Hao Li; Qiu Hong Huang; Hao Xiong; Zhi Gang Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.